Prediction for HBsAg seroconversion in children with chronic hepatitis B
Abstract Background To establish a prediction of HBsAg seroconversion in children with chronic hepatitis B (CHB), so as to help clinicians to choose therapeutic strategy. Methods A total of 63 children with HBeAg-positive CHB aged 1 to 17 years, who admitted to the fifth medical center of Chinese PL...
Guardado en:
Autores principales: | Yan-Wei Zhong, Yan-Min Shi, Fang Chu, Jie Liu, Ce Shi, Jiao-Jiao Xu, Peng Liu, Yan-Jie Bai, Xiao-He Xiao, Xiu-Chang Zhang, Min Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69472566622a47f4b653a246e8700597 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Aixin Song, et al.
Publicado: (2021) -
Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers
por: Mary C. Kuhns, et al.
Publicado: (2021) -
The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
por: Ying Wang, et al.
Publicado: (2021) -
Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant
por: Md. Golzar Hossain, et al.
Publicado: (2021) -
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021)